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INTRODUCTION
Extemporaneous medicines have some benefits 
over manufacturing drugs because they allow using 
a more streamline approach to each patient. Drugs 
prepared in the pharmacy offer a more individual 
approach to disease treatment, namely they allow to 
select doses of drug substance depending on the pa-
tient condition (1,2). Also compounded preparations 
provides the opportunity to change the substance 
composition taking into account patient allergies 
(3,4). These positive aspects are one of the main rea-
ABSTRACT
AIM: Tetracycline hydrochloride is one of the most popular antibiotics, which are used in the manufac-
turing of finished pharmaceutical products and compounded medicines. The aim of our work is develop-
ment and validation of the assay method for tetracycline hydrochloride determination in the combined 
compounded ointment.
MATERIALS AND METHODS: The assay is proposed to be carried out by spectrophotometric method.
RESULTS AND CONCLUSIONS: A spectrophotometric method for tetracycline hydrochloride determi-
nation in compounded ointment was developed. For this method the following validation characteristics 
were studied: stability, selectivity, repeatability, precision, accuracy, reproducibility. We found that all met-
rological characteristics are not higher than the validation criteria. Stability of test solutions was observed 
for 60 minutes, which allows using this method for tetracycline hydrochloride quantitative determination 
in studied ointment.
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sons, why we are observing the rebirth and expan-
sion of pharmaceutical technology in the pharmacies 
of Ukraine.
Such rapid growth leads to the necessity of de-
veloping new methods for qualitative and quantita-
tive control of compounded dosage forms, which al-
low the determining of the drug composition more 
accurately and quickly to ensure the provision of the 
highest quality of pharmaceutical care.
Tetracycline hydrochloride is one of the most 
often used antibiotics. It is the founder of one of the 
biggest group of antibacterial drugs. It has a bacterio-
static effect on a wide range of pathogens and is used 
in the treatment of pneumonia, dysentery, gonorrhea 
and the other infectious diseases (5,6).
Tetracycline hydrochloride is most often pro-
duced in the form tablets, capsules and suspensions, 
and rarely applied as an injection. It is frequent-
ly used externally as an ointment for treatment of 
burns, wounds and eye diseases. The manufactured 
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tetracycline ointment is often used as basis for a large 
number of compounded dosage forms, which have 
combined compositions and allow the expansion of 
the pharmacological effects of tetracycline hydro-
chloride by adding ingredients, which have another 
effect (6).
Pharmacopoeias suggest assay of tetracycline 
hydrochloride by chromatographic and biologi-
cal methods (7,8). But neither of these methods may 
be used in pharmacy conditions, because they need 
to have special expensive equipment, reagents and 
trained personnel for substance determination.
In addition to quality control of compounded 
preparations during the manufacturing and selling 
at the pharmacy, a development of accurate methods 
for ingredients assaying is also necessary for study-
ing the drug stability.
The aim of our work was development and vali-
dation of the tetracycline hydrochloride assay meth-
od in combined compounded ointment with the fol-
lowing composition:
MATERIALS AND METHODS
Analytical equipment composed of the follow-
ing appliances: Evolution 60S (Thermo, USA) spec-
trophotometer; AXIS ANG200 balances (Poland); 
pH-150 MI potentiometer (Ukraine) and Specord 
200 (Germany), was used for the analysis. The exper-
imental studies were conducted using class A mea-
suring glassware and excipients meeting the require-
ments of the State Pharmacopoeia of Ukraine (SPhU) 
(7), which is harmonized with the European ones (8).
Preparation of the dosage form test solution: 
0.5 g of ointment (accurate weight) was placed in a 
chemical glass, 5 ml of hexane R was added and in-
tensively stirred to dissolve the ointment base. The 
received solution was placed into a separating fun-
nel. The glass was washed with 3 ml of hexane R, 
also placing this in a separating funnel. Extraction of 
tetracycline hydrochloride was carried out by 10 ml 
portions of phosphate buffer solution (pH 4.5) with 
placing of the extract into a 100 ml volumetric flask 
each time. The last two times extraction was carried 
out by 5 ml portions of 0.1 M HCl solution. The ob-
tained solution was diluted to the 100 ml mark with 
phosphate buffer solution (pH 4.5) and mixed. The 
solution was filtered, 5.0 ml of it was transferred into 
a 25.0 ml volumetric flask and diluted to the mark by 
phosphate buffer solution with pH 4.5.
Preparation of the standard solution: 0.07 g of 
tetracycline hydrochloride reference standard (ac-
curate weight) was placed into a 100 ml volumetric 
flask, dissolved in 30 ml of phosphate buffer solution 
with pH 4.5, 5 ml of 0.1 M HCl was added, stirred and 
diluted to the 100 ml mark with phosphate buffer so-
lution (pH 4.5). After this, 2.0 ml of obtained solution 
was transferred into a 50 ml volumetric flask and di-
luted to the mark with the same solvent.
RESULTS AND DISCUSSION
The UV and visible spectrophotometry method 
was chosen as an assay method. This method allows 
the determination of the content of the organic com-
pounds accurately and inexpensively. The use of a ti-
trimetric method for analysis in this case is impossi-
ble, because the prescription is multicomponent and 
other components interfere with the analysis results.
At the first stage of the spectrophotometric pro-
cedure development, we studied the nature of tetra-
cycline hydrochloride spectra in different solvents, 
such as 0.1 M HCl, 0.1 M NaOH, phosphate buffered 
solution (pH 4.5), water R, ethanol R and methanol 
R.
Tetracycline undergoes reversible epimerisa-
tion in solution to the less active 4-epitetracycline; 
the degree of epimerisation is dependent on pH, and 
is greatest at a pH of about 3, with conversion of some 
55% to the epimer at equilibrium. The important re-
actions with the pH-dependent are formation of an-
hydrotetracycline at pH 2 or less, and oxidation to 
isotetracycline at alkaline solution (9).
The obtained results showed that tetracycline 
hydrochloride was unstable in alkaline medium. The 
absorption spectra of tetracycline hydrochloride in 
other solvents have broad absorption band in the UV 
area with a maximum at 269 nm (ethanol, methanol, 
HCl) or 277-279 nm (water and phosphate buffered 
solution), which is nonspecific and cannot be used 
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dosage forms by direct spectrophotometry method. 
Also absorption spectrum of tetracycline hydrochlo-
ride has a maximum in the visible area at 357-358 nm 
(for water solutions) or 362-363 nm (for alcoholic so-
lutions), which might be used for its assay in the stud-
ied ointment (Fig.1).
The next step in the assay method develop-
ment was sample preparation, during which the op-
timal way for tetracycline hydrochloride extraction 
from the ointment base and dosage form must be 
established.
Solutions of tetracycline in 0.1 M HCl and 0.1 M 
NaOH are unstable. When using water for extraction 
of tetracycline hydrochloride from the ointment, it 
undergoes partial hydrolysis to form the tetracycline 
base, which is insoluble in water, that is why it was 
decided to use methanol R for the extraction. Upon 
further study of this extraction method, we found 
that part of the ointment base was soluble in meth-
anol and affected negatively the results of the assay-
ing, making them higher. According to the literature 
data, extraction of tetracycline hydrochloride can be 
carried out with phosphate buffer solution, but direct 
extraction from the ointment base did not show pos-
itive results.
For the further development of the sample 
preparation method, we decided to dissolve the oint-
ment sample in minimum quantity of organic sol-
vent (hexane R) with the tetracycline hydrochloride 
extracting by phosphate buffer solution (pH 4.5). 
During the stability study of tetracycline hydrochlo-
ride solutions in the different solvents and extraction 
completeness, phosphate buffer solution (pH 4.5) 
showed the highest result. For this reason we chose it 
for the sample preparation.
Thus, we experimentally established, that the 
most optimal way for the sample preparation of this 
ointment was dissolution of accurate ointment sam-
ple in a minimum amount of hexane R with the 
further extraction of tetracycline hydrochloride by 
phosphate buffer solution (pH 4.5).
Since the studied ointment is multicomponent, 
we had to prove that all other components did not af-
fect the tetracycline hydrochloride absorption spec-
trum. We studied absorption spectra of substances 
and their mixture. We prepared solutions of sulfanil-
amide, procaine hydrochloride and tetracycline hy-
drochloride in concentration near to the prescribed 
in the ointment. We used the phosphate buffer solu-
tion (pH 4.5) as a solvent.
Results of studies have shown that procaine hy-
drochloride and sulfanilamide did not affect at the 
tetracycline hydrochloride maximum absorption 
at wavelength 357 nm. This allows the use of direct 
spectrophotometry for tetracycline hydrochloride 
assay in this ointment (Fig. 2).
One of the main requirements, which allows 
using spectrophotometric methods for substance as-
saying, is that it follows the Bouguer-Lambert-Beer 
law.
To check whether the substance solution light 
absorption follows the Bouguer-Lambert-Beer law, 
we need to draw graph dependence of the absorbance 
Fig. 1. The absorption spectra of tetracycline 
hydrochloride in different solvents.
Fig. 2. The absorption spectra of sulfanilamide, procaine 
hydrochloride, tetracycline hydrochloride and their mix-
ture in the phosphate buffer solution (pH 4.5).
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of the solution concentration. The light absorption of 
the solution obeys the Bouguer-Lambert-Beer law 
within the concentration, in which the constructed 
calibration graph appears as a straight line.
After a series of experimental studies we es-
tablished that the tetracycline hydrochloride solu-
tion obeys this law within concentrations from 0.5 to 
3.15*10-3 mg/ml, the specific absorbance is 342.5±8.5.
During the research, the suitable technique for 
tetracycline hydrochloride assay method in the stud-
ied ointment was offered.
Validation of the method was carried out in ac-
cordance with the SPhU requirements and the stan-
dard procedure for validation of the methods for 
quantitative determination of compounded medi-
cines in pharmacies and quality control laboratories 
(2,3). SPhU is harmonized with the requirements of 
EP that allow using this method all around the Eu-
rope. During the study the main validation charac-
teristics such as stability, selectivity, repeatability, pre-
cision, accuracy and reproducibility were considered.
To assess the sample preparation error of test 
and standard solutions, theoretical uncertainty val-
ues of analytical operations were calculated (4,5). 
The total uncertainty of the sample preparation for 
the developed method was: Δ
SP
=1.00 %.
During the validation of tetracycline hydro-
chloride assay method, some of the validation pa-
rameters were considered at first: the stability of test 
solution in time, linearity, repeatability and accura-
cy. Researches were conducted under the same con-
ditions: at the same day, on the same device and by 
the same analyst.
The stability testing of solution was carried 
out within 60 minutes for both the standard and the 
model solutions (A and А
0
 – mean value of the absor-
bance of three results for model and standard solu-
tions respectively).
The table above shows that the analytical solu-
tion is stable for 60 minutes, which allows using the 
developed method for the analysis.
To confirm the selectivity of the method, we 
calculated the systematic error by applying the sol-
vent and reagents to placebo. We measured the ab-
sorbance of blank and standard solutions.
Ointment without tetracycline hydrochloride 
was prepared as placebo. Blank solution (А blank) 
was prepared by the same method as the test solu-
tion. Absorbance measurements of blank (А blank) 
and standard (А st) solutions were conducted in par-
allel. We obtained the following results: А blank 
=0.006; A st =0.974, which confirm the absence of 
significant influence on the measurement results.
The study of linearity was carried out by the 
standardized procedure by measuring the absor-
bance of 9 model solutions, as recommended by 
SPhU, for assay of active pharmaceutical ingredients 
in dosage forms from 80% to 120% in increments of 
5%. The results are presented in Table 3 and Fig. 3.
We calculated the ratio of mean absorbance val-
ues for each of the solutions to the mean absorbance 
of the reference solution, getting the magnitude of 
. We 
worked in the normalized coordinates by showing 
concentration and the analytical signal as a percent-
age of the nominal values. We found also the value of 
Solution






0 15 30 45 60
A 0.859 0.858 0.858 0.858 0.857 0.858 0.0589 0.13 1.02
A
0
0.957 0.956 0.957 0.956 0.956 0.956 0.0529 0.11 1.02
Table 1. Stability studies of analytical method in time
Fig. 3. Linearity for tetracycline hydrochloride in normal-
ized coordinates
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, which is the concentration found as 
a percentage of the entered.
Repeatability and accuracy were determined 
by calculating the mean values, the relative standard 
deviation, relative confidence interval, the critical 
value for repeatability of results, and systematic er-
ror (Table 2).
Precision was assessed based on the analysis 
of 9 model solutions of various series, that was con-
ducted in two various days and different analysts 
in the same laboratory. To prepare two different se-
ries, various ointments were made. For preparation 
of these series of dilutions, different laboratory mea-
suring glassware was used. During sample prepara-
tion and conducting method fluctuations of temper-
ature, humidity, barometric pressure and other fac-
tors inside the laboratory, which affect the analysis, 
were possible.
The method is correct, because ΔZ complies 
with the requirements: ΔZ%≤maxΔ
As
=0.78 %. The 
method has no significant error.
To investigate the reproducibility of this meth-
od in other laboratories, measuring of absorbance of 
Characteristic
Value
Laboratory №1 Laboratory №2
Repeatability and accuracy
Mean, Z,% 99.19 99.25
Relative standard deviation, S
z
,% 0.5066 0.1837
Relative condence interval, Δ
z
,% 0.9421 0.3416
Critical value for repeatability of results, Δ
As
,% 3.20 3.20
Systematic error, δ 0.81 0.75
Statistically acceptable value, δ,% 0.31 0.11
Practically acceptable value, δ,% 1.02 1.02
Linearity




Free member of the linear dependence, a 0.0170 0.1572




'e correlation coe<cient, r 0.9993 0.9999
Criterion of the linear correlation coe<cient, R
c
0.9992 0.9999
Table 2. Assessment of accuracy and repeatability of the method





























Interlaboratory bias, δ, % 0.78










Table 3. Results of spectrophotometry method reproduc-
ibility study on model mixture
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the same series model ointment with tetracycline hy-
drochloride solutions on different equipment, on dif-
ferent days and in two different laboratories was car-
ried out (1,7).
The obtained results (shown in Table 3) are a 
comparison of two different statistical deviations 
measurements, which were conducted in different 
laboratories, using different equipment. Data show 
that the proposed method can be reproduced in oth-
er laboratories. It is characterized by relative confi-
dence interval 100±0.67% with 95% probability. The 
value of Δx, r, % = 0.67≤3.2.
CONCLUSIONS
The method for tetracycline hydrochloride as-
say in the compounded ointment was developed and 
validated. It has been established that the metrologi-
cal characteristics of such method validation param-
eters as stability, selectivity, repeatability, precision, 
accuracy, reproducibility do not exceed validation 
criteria. Stability of the test samples was observed 
within 60 minutes, which allows using this method 
for analysis of the compounded dosage form. The 
method can be reproduced in laboratory conditions, 
with a confidence interval of 95 % and a single value 
deviation of 100±0.67 %.
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